← All trials
NCT07029971
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 23, 2025
- Primary completion
- Mar 31, 2026
- Completion date
- Dec 31, 2026
- First posted
- Jun 19, 2025
- Last posted
- Sep 8, 2025
- Enrollment
- 34
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Battery Bio Australia Pty LtdLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.